GO
Loading...

Why AstraZeneca will be Pfizer's easiest takeover

Monday, 5 May 2014 | 6:30 PM ET

Raghuram Selvaraju, Head of Healthcare Equity Research at Aegis Capital, discusses Pfizer's motivations behind its takeover bid for U.K.-based AstraZeneca.